Europe Startup Funding Rounds
Startups raising capital across Europe. Compare the businesses, funding stages and investors active in the region.
- Rounds
- 242 Sep 30 – Oct 29, 2026
- Disclosed funding
- $4.2B 123 disclosed amounts
- Median round
- $6.5M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| A AutofixerCompany profile Autofixer runs an online car-parts marketplace that helps drivers identify compatible components. Autofixer runs an online car-parts marketplace that helps drivers identify compatible components. | €3M | Venture debtUndisclosed | Ecommerce | Poland | Investors | |
| MV Magic VisionCompany profile Magic Vision develops AI monitoring technology that helps care providers and families respond to falls and changes in daily activity. Magic Vision develops AI monitoring technology that helps care providers and families respond to falls and changes in daily activity. | €600K | Funding roundUndisclosed | Healthtech | Italy | Investors | |
| A ArtisoCompany profile Artiso builds an AI workspace connecting fashion design, product development and campaign production. Artiso builds an AI workspace connecting fashion design, product development and campaign production. | >€3M | Pre-seed | Enterprise software | Spain | Investors | |
| AR Arctic RAVNCompany profile Arctic RAVN designs and manufactures drone electronics in Finland for European defence customers. Arctic RAVN designs and manufactures drone electronics in Finland for European defence customers. | €2.5M | Convertible loan commitmentsUndisclosed | Defense tech | Finland | Investors Undisclosed | |
| L LoveyCompany profile Lovey provides business loans and credit brokerage for UK small and medium-sized companies. Lovey provides business loans and credit brokerage for UK small and medium-sized companies. | £50M | Senior secured credit facilityUndisclosed | Fintech | United Kingdom | Investors | |
| AB Atlas BioCompany profile Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions. Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions. | $10M | Seed | Biotech | Switzerland | Investors | |
| AL Agora LabsCompany profile Agora Labs connects clinical data across healthcare organisations for research while keeping patient records within hospital systems. Agora Labs connects clinical data across healthcare organisations for research while keeping patient records within hospital systems. | €4.3M | FundingUndisclosed | Healthtech | Italy | Investors | |
| AB Atlas BioCompany profile Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions. Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions. | $2.5M | Previously undisclosed pre-seedPre-seed | Biotech | Switzerland | Investors | |
| Q QuerioCompany profile Querio provides AI analytics tools built around shared business definitions that data teams can review and maintain. Querio provides AI analytics tools built around shared business definitions that data teams can review and maintain. | Undisclosed | Seed financingSeed | Enterprise software | United Kingdom | Investors | |
| M MachentaCompany profile Machenta develops AI models that help robots learn physical tasks from demonstrations. Machenta develops AI models that help robots learn physical tasks from demonstrations. | $40M | Seed | Robotics | United Kingdom | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Sep 30, 2026
- 1EU Innovation Fund
Epyr, Reverion, H2SITE
17rounds0led - 2NVIDIA
Riverlane, Foresight, Hiverge
7rounds0led - 3Creandum
Atlas Bio, Machenta, 22one
6rounds2led - 4Portfolio Ventures
Marrow, IMMIX, Cleavr
4rounds0led - 5Innovate UK
Emerald, Go Eve, Affinity Labs
4rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.